n Obstetrics and Gynaecology Forum - Bayer Schering Pharma - introduces a new paradigm in oral contraception with the launch of YAZ® : product news

Volume 19, Issue 3
  • ISSN : 1027-9148



Bayer Schering Pharma is proud to introduce YAZ®, the first low-dose drospirenone plus ethinylestradiol combination oral contraceptive in the optimised '24/4' regimen. YAZ® is the only oral contraceptive in South Africa with 3 registered indications; oral contraceptive; treatment of moderate acne vulgaris in women seeking oral contraception; treatment of premenstrual dysphoric disorder (PMDD) symptoms in women who have chosen oral contraception as their method of birth control.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error